Treatment of Adult-Onset Dermographism
Second-generation H1-antihistamines (such as fexofenadine 180 mg, loratadine 10 mg, or cetirizine 10 mg) should be the first-line treatment for adult-onset dermographism, with updosing up to 4 times the standard dose if symptoms are not controlled 1, 2.
First-Line Treatment Approach
Start with a nonsedating second-generation H1-antihistamine at standard dosing:
- Fexofenadine 180 mg daily
- Loratadine 10 mg daily
- Cetirizine 10 mg daily (mildly sedating but acceptable)
The evidence strongly supports second-generation antihistamines as uniformly effective and well-tolerated across all studies 1. In contrast, first-generation antihistamines showed variable efficacy with significant side effects and should be avoided except in short-term or palliative settings 3, 1.
Escalation Strategy for Inadequate Response
If standard-dose monotherapy fails after 2-4 weeks:
Step 1: Updose the second-generation H1-antihistamine up to 4-fold (e.g., fexofenadine up to 720 mg daily, cetirizine up to 40 mg daily). While no specific studies exist on updosing in dermographism, this recommendation is extrapolated from chronic spontaneous urticaria evidence and endorsed by international guidelines 1, 2.
Step 2: Add an H2-antihistamine (e.g., cimetidine) to the H1-antihistamine regimen. H2-antihistamines are ineffective as monotherapy but enhance efficacy when combined with H1-blockers 3, 1.
Step 3: Consider omalizumab for refractory cases not responding to maximized antihistamine therapy. Omalizumab has demonstrated improvement in symptomatic dermographism, though evidence is limited 1, 2.
Alternative Second-Line Options
For antihistamine-resistant cases, narrowband UVB phototherapy (3 times weekly for 6 weeks) is an effective option, showing 52% reduction in itching and 71% reduction in whealing 4, 5. This can restore antihistamine responsiveness in some patients, though symptoms may relapse within 12-18 weeks after completing phototherapy 4.
Important Caveats
- Avoid sedating antihistamines (like hydroxyzine) except for short-term use, as they have significant side effects without superior efficacy 3, 1
- Avoid topical treatments such as capsaicin, calamine lotion, or crotamiton cream—these are not recommended 3
- Emollients and trigger avoidance should be advised as adjunctive measures 3, 2
- Calcium channel blockers (nifedipine) are not effective and cause frequent side effects 6
Clinical Monitoring
The Urticaria Control Test (UCT), Chronic Urticaria Quality of Life questionnaire (CU-Q2oL), and Dermatology Life Quality Index (DLQI) are validated tools for assessing disease control 2. Routine inflammatory markers (CRP, basophil counts) show some differences between dermographism and other urticarias but do not guide treatment decisions 7.